Skip to main content
LobbyMap

Federal Pharma Technologies

Finance & Banking · Lobbying Client

C
Influence Score
46/100
Moderate Influence
$1.0M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door

Federal Pharma Technologies reported $1.0 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Banking, Financial Institutions, Taxation. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Energy
US Senate
Federal Trade Commission
Dept of Commerce
US House of Representatives
Federal Communications Commission
Dept of Transportation
Small Business Administration
Dept of Education

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarBrownstein Hyatt LLP
GOVBAN
1$43K
2020 Apr-JunAkin Gump LLP
TAXAPPBAN
1$51K
2020 Jul-SepBGR Group LLP
BAN
1$60K
2020 Oct-DecAkin Gump LLP
BAN
1$47K
2021 Jan-MarBGR Group LLP
GOVBANAPP
1$74K
2021 Apr-JunBGR Group LLP
TAX
1$60K
2021 Jul-SepHolland & Knight LLP
FINBANTAX
1$65K
2021 Oct-DecCassidy & Associates LLP
MEDBAN
1$71K

Federal Pharma Technologies Lobbying FAQ

Federal Pharma Technologies has spent $1.0M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Federal Pharma Technologies lobbies on 6 policy issues, including Banking, Financial Institutions, Taxation, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Federal Pharma Technologies has an Influence Score of 46/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Federal Pharma Technologies employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Federal Pharma Technologies has contacted 9 government entities as part of their lobbying activities, including Dept of Energy, US Senate, Federal Trade Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.